Healixia Clinical Conference
- 22 okt 2025
- 1 minuten om te lezen
From clinical insights to candlelit conversations!
Last week, our CEO, Evelyne Vermeersch, joined the Healixia Clinical Conference, followed by the BioWin Annual Dinner — a day where sharp minds met forward-thinking moves – and the future felt a little closer!
🧭 Major topic of the day? Belgium is stepping up.
Starting January 1, 2026, initial applications for mononational Phase I–II trials will be assessed within 20 days, and Phase II/III–IV trials within 35 days (provided no rfi is issued).
⚡️ Faster reviews. Smoother pathways. More reasons to say: "Let’s trial in Belgium."
As the sun set on PowerPoints and policy talks, we dimmed the lights, raised our glasses, and leaned into the kind of conversations that don’t require slide decks.
The stunning Palais d’Afrique set the mood for networking, note-sharing, and maybe too many dessert bites.
Big thanks to everyone who sparked an idea, shared a vision, or just made us laugh.
Here’s to clinical trials that move faster, partnerships that last longer, and progress that actually feels like progress.
